News
-
Aptar Pharma has transferred manufacturing equipment for its Child-Resistant and Senior-Friendly Classic Nasal Pump from a plant in Germany to its facility in Congers, NY, the company said. According to Aptar, its child-resistant pump is… Read more . . .
-
Egalet Corporation has announced that Ascend Therapeutics will begin co-promoting Egalet’s Sprix ketorolac tromethamine nasal spray to women’s healthcare practitioners in the US in the third quarter of 2017 and will continue for at least… Read more . . .
-
Device company Nemera has announced a partnership with the Research Center for Respiratory Diseases (CEPR) at the University of Tours for investigation of a novel intranasal drug delivery method. Nemera, which was formerly known as… Read more . . .
-
Anyone wishing to enter the competition for the new DDL Emerging Scientist award should submit their CV and a 1000-word synopsis of their work by June 30, 2017. The winner will present the DDL Emerging… Read more . . .
-
US grocer Albertsons will begin selling Lupin’s InspiraChamber antistatic valved holding chamber exclusively in more than 1,700 pharmacies in 35 US states, Lupin has announced. The InspiraChamber spacer can be used with one of several… Read more . . .
-
MannKind Corporation has announced the appointment of Michael Castagna as Chief Executive Officer, effective May 25, 2017. Castagna takes over the role from Matthew Pfeffer, who succeeded Alfred Mann as CEO in January 2016. Pfeffer… Read more . . .
-
According to Sunovion, the FDA has issued a complete response letter (CRL) for its NDA for SUN-101/eFlow glycopyrrolate inhalation solution for the treatment of COPD. Sunovion submitted the NDA for SUN-101/eFlow in July 2016, and… Read more . . .
-
Elran Haber, CEO of Therapix Biosciences, which is developing intranasal cannabinoid-based drugs, will step down “to pursue other professional opportunities” after the company concludes its search for “a permanent, US based Chief Executive Officer,” the… Read more . . .
-
Horizon Pharma has agreed to sell Raptor Pharmaceuticals, which owns the rights to Quinsair levofloxacin inhalation solution in Europe, the Middle East and Africa, to Chiesi Farmaceutici for $70 million and potential sales-based milestone payments,… Read more . . .
-
Generic device company Merxin has announced the launch of its MRX003 dry powder inhaler, an off-the-shelf capsule based DPI intended for generic tiotropium 505j submissions. According to an announcement by Merxin’s sister company Aedestra, the… Read more . . .
Upcoming Events
Sponsored by Intertek
Want information about upcoming OINDP-related events delivered directly to your inbox? click here
July 13-July 16: 2026 ISAM Congress, Taipei, Taiwan
September 15-September 18: DDL New Researcher Network Summer Event, London, UK
September 16-September 17: IPAC-RS 2026 Nasal Innovation Forum, Jersey City, NJ, USA
September 24-September 25: Inhaled & Nasal Biologics | DNA Forum, Cambridge, UK
October 14-October 15: Advancing Bioequivalence Frameworks for Inhalation and Nasal Drug Products: Optimizing In Vitro, In Vivo, and In Silico Methods, Rockville, MD, USA